Scientists have warned that a diabetes drug could increase the risk of developing a potentially fatal gangrene which causes the genitals to rot away. The researchers looked at the side effects of ...

In August 2018, the US Food and Drug Administration (FDA) added a warning about Fournier gangrene (FG) to the labels of all SGLT2 inhibitors, used to treat type 2 diabetes. And as reported by Medscape ...

Fournier gangrene (FG), a necrotizing infection of the perineum, is a relatively rare but potentially fatal complication of treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors, new data ...

Aug. 30 (UPI) --The U.S. Food and Drug Administration has issued a warning that a class of type 2 diabetes drugs in rare cases might cause a flesh-eating bacterial infection of genitals. The condition ...

FDA Logo The infection developed within several months of the patients starting SGLT2 therapy and the drug was discontinued in most cases. All patients required surgery and there was 1 reported death.

After the FDA last year slapped a warning label on SGLT2 diabetes drugs, detailing risks of an infection with a rare flesh-eating bacteria, a team of researchers has come out with a new set of numbers ...

The operation was performed, in general, for diabetic gangrene distal to the ankle. There were no cases of gangrene or uncontrolled sepsis above the ankle. In 51 cases the procedure was done in one ...

Major amputation remains a significant complication of patients with diabetic foot problems. Now, research indicates the predictive factors for below-and above-the-knee amputation in these patients.

This 2723- female infant was born at 35 weeks' gestation to a 28-year-old gravida 3, para 0 mother. The pregnancy was complicated by type 1 insulin-dependent diabetes of 16 years' duration. The mother ...

Sleep regularity - such as going to bed at a consistent time - is a little known but critical factor in disease risk, researchers said GOING to sleep past a specific time could up the risk of 92 ...

FDA LOGO BLUE The infection developed within several months of the patients starting SGLT2 therapy and the drug was discontinued in most cases. All patients required surgery and there was 1 reported ...